HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ick Chan Kwon Selected Research

poly(beta-amino ester)

6/2010Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy.
2/2010Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
11/2007Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ick Chan Kwon Research Topics

Disease

175Neoplasms (Cancer)
07/2022 - 08/2003
12Breast Neoplasms (Breast Cancer)
11/2017 - 05/2008
8Thrombosis (Thrombus)
01/2021 - 12/2011
8Atherosclerosis
01/2020 - 10/2008
8Melanoma (Melanoma, Malignant)
12/2013 - 02/2005
6Rheumatoid Arthritis
06/2019 - 11/2008
5Stroke (Strokes)
01/2021 - 05/2013
5Atherosclerotic Plaque (Atheroma)
10/2018 - 06/2008
5Inflammation (Inflammations)
01/2017 - 03/2010
4Neoplasm Metastasis (Metastasis)
07/2022 - 05/2008
4Arthritis (Polyarthritis)
06/2019 - 12/2011
4Experimental Arthritis
10/2015 - 12/2011
4Colonic Neoplasms (Colon Cancer)
09/2012 - 12/2009
4Osteoarthritis
01/2012 - 09/2008
3Carcinogenesis
01/2020 - 12/2010
3Wounds and Injuries (Trauma)
01/2020 - 11/2018
3Cardiotoxicity
01/2019 - 12/2010
3Infarction (Infarctions)
01/2018 - 12/2016
3Infections
01/2018 - 06/2005
3Hemorrhage
01/2017 - 05/2008
3Ischemia
12/2016 - 09/2013
2Prostatic Neoplasms (Prostate Cancer)
11/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

49Pharmaceutical PreparationsIBA
07/2022 - 05/2008
46glycol-chitosanIBA
12/2020 - 08/2003
30Small Interfering RNA (siRNA)IBA
01/2020 - 09/2009
26Peptides (Polypeptides)IBA
01/2022 - 03/2004
21Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 08/2003
16Hyaluronic Acid (Hyaluronan)IBA
11/2018 - 01/2010
15Matrix Metalloproteinases (MMPs)IBA
01/2016 - 09/2008
14MicellesIBA
11/2019 - 11/2007
13Drug CarriersIBA
07/2022 - 04/2008
13LigandsIBA
12/2017 - 08/2008
12Photosensitizing Agents (Photosensitizers)IBA
12/2019 - 05/2009
12GoldIBA
01/2018 - 12/2010
12PolymersIBA
10/2017 - 02/2007
11Coloring Agents (Dyes)IBA
01/2017 - 12/2009
10Proteins (Proteins, Gene)FDA Link
10/2020 - 07/2010
10Poloxamer (Poloxamer 407)IBA
10/2018 - 05/2010
91-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2019 - 01/2011
9Biological ProductsIBA
01/2018 - 08/2008
7Therapeutic UsesIBA
01/2018 - 05/2008
7Liposomes (Liposome)IBA
12/2017 - 12/2009
7Docetaxel (Taxotere)FDA Link
10/2016 - 05/2008
7CY5.5 cyanine dyeIBA
01/2016 - 10/2007
7Heparin (Liquaemin)FDA LinkGeneric
12/2014 - 05/2008
7Paclitaxel (Taxol)FDA LinkGeneric
12/2013 - 02/2005
7ChitosanIBA
05/2012 - 08/2003
6Singlet OxygenIBA
12/2019 - 01/2011
5ProdrugsIBA
12/2020 - 02/2015
5CollagenIBA
01/2020 - 09/2012
5Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 05/2009
5HydrogelsIBA
11/2018 - 02/2007
4EnzymesIBA
10/2020 - 12/2009
4Caspase 3 (Caspase-3)IBA
12/2019 - 02/2015
4Cathepsin BIBA
01/2019 - 01/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017 - 12/2015
4AzidesIBA
12/2017 - 03/2014
4IntegrinsIBA
01/2017 - 12/2012
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 05/2013
4Contrast MediaIBA
05/2016 - 01/2014
4Ethylene Glycol (Monoethylene Glycol)IBA
06/2013 - 08/2008
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2011 - 05/2008
3PolyethyleneimineIBA
01/2020 - 06/2010
3Neoplasm Antigens (Tumor Antigens)IBA
01/2020 - 10/2016
3Oxygen (Dioxygen)IBA
12/2019 - 07/2013
3CytokinesIBA
10/2019 - 02/2014
3Biocompatible Materials (Biomaterials)IBA
01/2019 - 08/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 03/2013
3AntigensIBA
01/2018 - 02/2015
3Polysaccharides (Glycans)IBA
01/2017 - 11/2016
3AcidsIBA
01/2017 - 06/2010
3Dextran SulfateIBA
01/2017 - 01/2014
3CaspasesIBA
01/2016 - 02/2011
3DisulfidesIBA
11/2014 - 10/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2014 - 11/2008
3CeramidesIBA
01/2014 - 10/2011
3Peptide Hydrolases (Proteases)FDA Link
01/2012 - 03/2010
3Fluorescein-5-isothiocyanate (FITC)IBA
10/2011 - 08/2003
3protoporphyrin IXIBA
06/2011 - 05/2009
3poly(lactide) (polylactic acid)IBA
06/2010 - 08/2008
3monomethoxypolyethylene glycol (MPEG)IBA
06/2010 - 11/2007
3poly(beta-amino ester)IBA
06/2010 - 11/2007
3EmulsionsIBA
10/2006 - 02/2005
2OvalbuminIBA
10/2021 - 02/2015
2Epidermal Growth Factor (EGF)IBA
12/2020 - 12/2013
2ErbB Receptors (EGF Receptor)IBA
12/2020 - 12/2013
2AntibodiesIBA
10/2020 - 08/2008
2Lysine (L-Lysine)FDA Link
11/2019 - 08/2014
2Messenger RNA (mRNA)IBA
11/2018 - 07/2015
2Apolipoproteins E (ApoE)IBA
10/2018 - 01/2013

Therapy/Procedure

84Therapeutics
07/2022 - 02/2007
16Precision Medicine
12/2020 - 04/2011
13Intravenous Injections
10/2020 - 02/2007
11Photochemotherapy (Photodynamic Therapy)
12/2019 - 08/2010
10Drug Therapy (Chemotherapy)
12/2017 - 02/2007
8Intravenous Administration
02/2016 - 01/2006
6Immunotherapy
11/2020 - 02/2015
5Lasers (Laser)
07/2015 - 06/2010
4Photothermal Therapy
01/2017 - 12/2010
3Urinary Catheters
01/2003 - 10/2002